Matthew D. Perry

Director, CTI BioPharma.

Companies

XOMA Royalty CorpBoard member May 20, 2022 to now¹
CTI BioPharmaBoard member Mar 12, 2021 to Jun 26, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

XOMA Royalty Corp0 shares³Jul 14, 2026
CTI BioPharma0 shares⁴Jun 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 14, 2026Other 24,138 shares of XOMA Royalty Corp³
May 21, 2026Granted 3,586 shares of XOMA Royalty Corp⁵
May 21, 2025Granted 5,971 shares of XOMA Royalty Corp⁶
May 15, 2024Granted 6,070 shares of XOMA Royalty Corp⁷
Jun 26, 2023U 43,139 shares at $9.10 of CTI BioPharma⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXOMA Royalty Corp, Board member
2
SEC EDGARCTI BioPharma, Board member
3
SEC EDGARXOMA Royalty Corp shares after the filing of Jul 14, 2026
4
SEC EDGARCTI BioPharma shares after the filing of Jun 26, 2023
5
SEC EDGARForm 4 filed May 26, 2026
6
SEC EDGARForm 4 filed May 23, 2025
7
SEC EDGARForm 4 filed May 17, 2024